US Stock MarketDetailed Quotes

NTLA Intellia Therapeutics

Watchlist
  • 8.200
  • -0.280-3.30%
Close Apr 29 16:00 ET
  • 8.350
  • +0.150+1.83%
Pre 05:30 ET
848.84MMarket Cap-1.56P/E (TTM)

Intellia Therapeutics Key Stats

Intellia Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 19 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 11.967M--
--2025/Q1-- / 11.986M--
Feb 27, 20252024/Q412.874M / 8.100M--
Nov 7, 20242024/Q39.111M / 7.170M--
Aug 8, 20242024/Q26.957M / 18.277M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 11.967M--
--2025/Q1-- / 11.986M--
Feb 27, 20252024/Q412.874M / 8.100M--
Nov 7, 20242024/Q39.111M / 7.170M--
Aug 8, 20242024/Q26.957M / 18.277M--

Unlock Free Earnings Estimates

Intellia Therapeutics Earnings Reports

Read more

Market Insights

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.